Literature DB >> 22115773

Substance P-neurokinin-1 receptor interaction upregulates monocyte tissue factor.

Mohammad M Khan1, Steven D Douglas, Tami D Benton.   

Abstract

Monocytes play an important role in hemostasis. In this study, the prothrombotic effects of the neuropeptide substance P (SP) on human monocytes through neurokinin-1 receptor (NK1-R) were characterized. SP upregulated monocyte tissue factor (TF), the major coagulation cascade stimulator, in a concentration and time dependent manner. Specific inhibition of NK1-R completely blocked TF expression. Monocytes stimulated by SP released cytokines and chemokines. When monocytes were stimulated with cytokines or chemokines, TF was expressed by the cytokines (GM-CSF, IFN-γ and TNF-α). Cytokines may play a major role in the mechanism of SP induced monocyte TF expression. NK1-R antagonists (NK1-RA) may have a role in developing novel therapeutic approaches to patients vulnerable to vaso-occlusive disorders.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22115773      PMCID: PMC3278501          DOI: 10.1016/j.jneuroim.2011.10.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  41 in total

1.  Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.

Authors:  J P Lai; W Z Ho; G X Zhan; Y Yi; R G Collman; S D Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 2.  Tachykinin-mediated modulation of the immune response.

Authors:  Kenneth L Bost
Journal:  Front Biosci       Date:  2004-09-01

3.  HIV enhances substance P expression in human immune cells.

Authors:  Wen-Zhe Ho; Jian-Ping Lai; Yuan Li; Steven D Douglas
Journal:  FASEB J       Date:  2002-04       Impact factor: 5.191

4.  Mast cell heterogeneity: effects of neuroenteric peptides on histamine release.

Authors:  F Shanahan; J A Denburg; J Fox; J Bienenstock; D Befus
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

5.  A substance P antagonist improves outcome when administered 4 h after onset of ischaemic stroke.

Authors:  Renée J Turner; Stephen C Helps; Emma Thornton; Robert Vink
Journal:  Brain Res       Date:  2011-04-03       Impact factor: 3.252

6.  CD40L stabilizes arterial thrombi by a beta3 integrin--dependent mechanism.

Authors:  Patrick André; K S Srinivasa Prasad; Cécile V Denis; Ming He; Jessie M Papalia; Richard O Hynes; David R Phillips; Denisa D Wagner
Journal:  Nat Med       Date:  2002-03       Impact factor: 53.440

7.  Elevated substance P levels in HIV-infected men.

Authors:  S D Douglas; W Z Ho; D R Gettes; A Cnaan; H Zhao; J Leserman; J M Petitto; R N Golden; D L Evans
Journal:  AIDS       Date:  2001-10-19       Impact factor: 4.177

8.  Exaggerated IL-8 and IL-6 responses to TNF-alpha by parainfluenza virus type 4-infected NCI-H292 cells.

Authors:  Thierry Roger; Paul Bresser; Mieke Snoek; Koen van der Sluijs; Arjen van den Berg; Monique Nijhuis; Henk M Jansen; René Lutter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-07-23       Impact factor: 5.464

9.  Calibrated automated thrombin generation measurement in clotting plasma.

Authors:  H Coenraad Hemker; Peter Giesen; Raed Al Dieri; Véronique Regnault; Eric de Smedt; Rob Wagenvoord; Thomas Lecompte; Suzette Béguin
Journal:  Pathophysiol Haemost Thromb       Date:  2003

10.  Substance P recognition by a subset of human T lymphocytes.

Authors:  D G Payan; D R Brewster; A Missirian-Bastian; E J Goetzl
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

View more
  5 in total

Review 1.  Neurokinin receptors and their implications in various autoimmune diseases.

Authors:  Amrita Mishra; Girdhari Lal
Journal:  Curr Res Immunol       Date:  2021-07-01

2.  Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor.

Authors:  Sergei Spitsin; Florin Tuluc; John Meshki; Jian Ping Lai; Richard Tustin Iii; Steven D Douglas
Journal:  Neuroimmunomodulation       Date:  2013-07-05       Impact factor: 2.492

3.  Increased M1/decreased M2 signature and signs of Th1/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia.

Authors:  P Brambilla; M Bellani; M Isola; A Bergami; V Marinelli; N Dusi; G Rambaldelli; M Tansella; A Maria Finardi; G Martino; C Perlini; R Furlan
Journal:  Transl Psychiatry       Date:  2014-07-01       Impact factor: 6.222

4.  Substance P and Chronic Pain in Patients with Chronic Inflammation of Connective Tissue.

Authors:  Barbara Lisowska; Aleksander Lisowski; Katarzyna Siewruk
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

Review 5.  The Role of Substance P in the Regulation of Bone and Cartilage Metabolic Activity.

Authors:  Fu-Xing-Zi Li; Feng Xu; Xiao Lin; Feng Wu; Jia-Yu Zhong; Yi Wang; Bei Guo; Ming-Hui Zheng; Su-Kang Shan; Ling-Qing Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-28       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.